Masayuki Ide

420 total citations
20 papers, 256 citations indexed

About

Masayuki Ide is a scholar working on Molecular Biology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Masayuki Ide has authored 20 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Psychiatry and Mental health and 4 papers in Clinical Psychology. Recurrent topics in Masayuki Ide's work include Dementia and Cognitive Impairment Research (4 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Masayuki Ide is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Masayuki Ide collaborates with scholars based in Japan, Australia and United States. Masayuki Ide's co-authors include David A. Lewis, Takashi Asada, Kazuo Yamada, Takeo Yoshikawa, Tomoko Toyota, Yoshimi Iwayama, Tetsuo Ohnishi, Norio Mori, Izuru Matsumoto and Akihiko Takashima and has published in prestigious journals such as Scientific Reports, Biological Psychiatry and Journal of Neurochemistry.

In The Last Decade

Masayuki Ide

19 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Ide Japan 8 133 80 69 45 30 20 256
Noriko Miyazaki Japan 11 67 0.5× 118 1.5× 48 0.7× 94 2.1× 17 0.6× 17 329
Réka Kovács-Nagy Hungary 13 168 1.3× 37 0.5× 82 1.2× 56 1.2× 61 2.0× 22 363
Alessia Fiorentino United Kingdom 9 200 1.5× 58 0.7× 89 1.3× 21 0.5× 44 1.5× 15 335
Karin Kojima Japan 9 129 1.0× 65 0.8× 105 1.5× 65 1.4× 50 1.7× 18 311
Calwing Liao Canada 10 125 0.9× 76 0.9× 70 1.0× 29 0.6× 45 1.5× 21 258
Sara Guzzetti Italy 11 115 0.9× 109 1.4× 75 1.1× 29 0.6× 23 0.8× 17 325
Christos Ballas United States 5 103 0.8× 101 1.3× 51 0.7× 20 0.4× 53 1.8× 8 230
Fiona Middle United Kingdom 8 76 0.6× 48 0.6× 56 0.8× 26 0.6× 67 2.2× 9 215
A C Sherwood United States 6 218 1.6× 66 0.8× 156 2.3× 25 0.6× 19 0.6× 9 379
Jue Ji China 12 177 1.3× 68 0.8× 148 2.1× 37 0.8× 89 3.0× 27 378

Countries citing papers authored by Masayuki Ide

Since Specialization
Citations

This map shows the geographic impact of Masayuki Ide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Ide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Ide more than expected).

Fields of papers citing papers by Masayuki Ide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Ide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Ide. The network helps show where Masayuki Ide may publish in the future.

Co-authorship network of co-authors of Masayuki Ide

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Ide. A scholar is included among the top collaborators of Masayuki Ide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Ide. Masayuki Ide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ota, Miho, Miyuki Nemoto, Kiyotaka Nemoto, et al.. (2022). Effects of a multicomponent day‐care program on cerebral blood flow in patients with mild cognitive impairment. Psychogeriatrics. 22(4). 478–484. 1 indexed citations
2.
Ota, Miho, et al.. (2022). Relationships between the Fear of COVID-19 Scale and regional brain atrophy in mild cognitive impairment. Acta Neuropsychiatrica. 34(3). 153–162. 4 indexed citations
3.
Ota, Miho, Miyuki Nemoto, Kiyotaka Nemoto, et al.. (2022). The Multicomponent Day-Care Program Prevents Volume Reduction in a Memory-Related Brain Area in Patients with Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. 51(2). 120–127.
4.
Tachikawa, Hirokazu, Miho Ota, Masashi Tamura, et al.. (2022). Association between behavioural and psychological symptoms of dementia and residence status in patients with Alzheimer's disease. Psychogeriatrics. 23(1). 45–51. 1 indexed citations
5.
Ide, Masayuki, et al.. (2019). A novel approach for assessing neuromodulation using phase-locked information measured with TMS-EEG. Scientific Reports. 9(1). 428–428. 9 indexed citations
6.
Sato, Shinji, et al.. (2019). Mutism in an adult case with autism spectrum disorder improved by aripiprazole. 10(0). 26–28. 1 indexed citations
7.
Ide, Masayuki, et al.. (2018). Imaging studies of kleptomania in a middle‐aged woman with obsessive–compulsive disorder: a case report. Psychogeriatrics. 18(5). 430–433. 1 indexed citations
8.
Balan, Shabeesh, Yoshimi Iwayama, Motoko Maekawa, et al.. (2014). Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects. Molecular Autism. 5(1). 49–49. 21 indexed citations
9.
Balan, Shabeesh, Yoshimi Iwayama, Kazuo Yamada, et al.. (2014). Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia. Journal of Neural Transmission. 122(3). 477–485. 3 indexed citations
10.
Ide, Masayuki & David A. Lewis. (2010). Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits. Biological Psychiatry. 68(1). 25–32. 85 indexed citations
11.
Ide, Masayuki, Tetsuo Ohnishi, Miyuki Murayama, et al.. (2006). Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. Journal of Neurochemistry. 99(1). 277–287. 51 indexed citations
12.
Ide, Masayuki, Kazuo Yamada, Tomoko Toyota, et al.. (2005). Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: evidence for association of ASCL1 with Parkinson’s disease. Human Genetics. 117(6). 520–527. 23 indexed citations
13.
Ide, Masayuki, et al.. (2004). A case of neurosyphilis showing a marked improvement of clinical symptoms and cerebral blood flow on single photon emission computed tomography with quantitative penicillin treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(2). 417–420. 9 indexed citations
14.
Ide, Masayuki, Tatsuyuki Muratake, Kazuo Yamada, et al.. (2004). Genetic and expression analyses of FZD3 in schizophrenia. Biological Psychiatry. 56(6). 462–465. 24 indexed citations
15.
Ide, Masayuki, Katsuyoshi Mizukami, Toshihito Suzuki, & Hiroyasu Shiraishi. (2000). A case of temporal lobe epilepsy with improvement of clinical symptoms and single photon emission computed tomography findings after treatment with clonazepam. Psychiatry and Clinical Neurosciences. 54(5). 595–597. 7 indexed citations
16.
Ide, Masayuki, et al.. (1997). [1H-MRSI of Alzheimer's disease].. PubMed. 55(7). 1768–73. 3 indexed citations
17.
Yamamoto, Masaya, et al.. (1996). Is Unchanged Tumor Volume after Radiosurgery a Measure of Outcome?. Stereotactic and Functional Neurosurgery. 66(1). 231–239. 7 indexed citations
18.
Ide, Masayuki, et al.. (1988). [Microtumor presenting with temporal lobe epilepsy--a case report].. PubMed. 16(4). 415–9. 1 indexed citations
19.
Ide, Masayuki, et al.. (1971). A Simplified Method for Plasma Inorganic Iodine (PII) Estimation. Folia Endocrinologica Japonica. 46(10). 1062–1065,1053. 2 indexed citations
20.
Yoshida, Hideo, et al.. (1967). A Case Report of Idiopathic Decrease in Thyroxine Binding Globulin (TBG). Folia Endocrinologica Japonica. 42(11). 1200–1203,1191. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriko Miyazaki Breakdown of academic impact, for papers by Réka Kovács-Nagy Breakdown of academic impact, for papers by Alessia Fiorentino Breakdown of academic impact, for papers by Karin Kojima Breakdown of academic impact, for papers by Calwing Liao Breakdown of academic impact, for papers by Sara Guzzetti Breakdown of academic impact, for papers by Christos Ballas Breakdown of academic impact, for papers by Fiona Middle Breakdown of academic impact, for papers by A C Sherwood Breakdown of academic impact, for papers by Jue Ji
Rankless by CCL
2026